Global Paliperidone Market Size, Status and Forecast 2021-2027

パリペリドンの世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Paliperidone Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3928
◆調査・発行会社:QYResearch
◆発行日:2021年6月
◆ページ数:86
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥448,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥672,750見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、パリペリドンの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(1.5mg錠、3mg錠、6mg錠、9mg錠)、用途別市場規模(大人用、青年用)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・パリペリドンの市場動向
・企業の競争状況、市場シェア
・パリペリドンの種類別市場規模(1.5mg錠、3mg錠、6mg錠、9mg錠)
・パリペリドンの用途別市場規模(大人用、青年用)
・パリペリドンの北米市場規模2016-2027(アメリカ、カナダ)
・パリペリドンの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・パリペリドンのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・パリペリドンの中南米市場規模2016-2027(メキシコ、ブラジル)
・パリペリドンの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Janssen Pharmaceutica、Mylan、Teva、Sun Pharmaceutical)
・結論

Paliperidone, sold under the trade name Invega among others, is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class of medications. It is marketed by Janssen Pharmaceutica. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once-daily dosing. Paliperidone is mainly used to treat schizophrenia and schizoaffective disorder. It is also used to treat mania and at lower doses as maintenance for bipolar disorder.

Market Analysis and Insights: Global Paliperidone Market
The global Paliperidone market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Paliperidone market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Paliperidone market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Paliperidone market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Paliperidone market.

Global Paliperidone Scope and Market Size
Paliperidone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Paliperidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
1.5 mg Tablet
3 mg Tablet
6 mg Tablet
9 mg Tablet

Segment by Application
Adults
Adolescents

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Janssen Pharmaceutica
Mylan
Teva
Sun Pharmaceutical

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paliperidone Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 1.5 mg Tablet
1.2.3 3 mg Tablet
1.2.4 6 mg Tablet
1.2.5 9 mg Tablet
1.3 Market by Application
1.3.1 Global Paliperidone Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adults
1.3.3 Adolescents
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Paliperidone Market Perspective (2016-2027)
2.2 Paliperidone Growth Trends by Regions
2.2.1 Paliperidone Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Paliperidone Historic Market Share by Regions (2016-2021)
2.2.3 Paliperidone Forecasted Market Size by Regions (2022-2027)
2.3 Paliperidone Industry Dynamic
2.3.1 Paliperidone Market Trends
2.3.2 Paliperidone Market Drivers
2.3.3 Paliperidone Market Challenges
2.3.4 Paliperidone Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Paliperidone Players by Revenue
3.1.1 Global Top Paliperidone Players by Revenue (2016-2021)
3.1.2 Global Paliperidone Revenue Market Share by Players (2016-2021)
3.2 Global Paliperidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Paliperidone Revenue
3.4 Global Paliperidone Market Concentration Ratio
3.4.1 Global Paliperidone Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paliperidone Revenue in 2020
3.5 Paliperidone Key Players Head office and Area Served
3.6 Key Players Paliperidone Product Solution and Service
3.7 Date of Enter into Paliperidone Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Paliperidone Breakdown Data by Type
4.1 Global Paliperidone Historic Market Size by Type (2016-2021)
4.2 Global Paliperidone Forecasted Market Size by Type (2022-2027)

5 Paliperidone Breakdown Data by Application
5.1 Global Paliperidone Historic Market Size by Application (2016-2021)
5.2 Global Paliperidone Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Paliperidone Market Size (2016-2027)
6.2 North America Paliperidone Market Size by Type
6.2.1 North America Paliperidone Market Size by Type (2016-2021)
6.2.2 North America Paliperidone Market Size by Type (2022-2027)
6.2.3 North America Paliperidone Market Size by Type (2016-2027)
6.3 North America Paliperidone Market Size by Application
6.3.1 North America Paliperidone Market Size by Application (2016-2021)
6.3.2 North America Paliperidone Market Size by Application (2022-2027)
6.3.3 North America Paliperidone Market Size by Application (2016-2027)
6.4 North America Paliperidone Market Size by Country
6.4.1 North America Paliperidone Market Size by Country (2016-2021)
6.4.2 North America Paliperidone Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Paliperidone Market Size (2016-2027)
7.2 Europe Paliperidone Market Size by Type
7.2.1 Europe Paliperidone Market Size by Type (2016-2021)
7.2.2 Europe Paliperidone Market Size by Type (2022-2027)
7.2.3 Europe Paliperidone Market Size by Type (2016-2027)
7.3 Europe Paliperidone Market Size by Application
7.3.1 Europe Paliperidone Market Size by Application (2016-2021)
7.3.2 Europe Paliperidone Market Size by Application (2022-2027)
7.3.3 Europe Paliperidone Market Size by Application (2016-2027)
7.4 Europe Paliperidone Market Size by Country
7.4.1 Europe Paliperidone Market Size by Country (2016-2021)
7.4.2 Europe Paliperidone Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Paliperidone Market Size (2016-2027)
8.2 Asia-Pacific Paliperidone Market Size by Type
8.2.1 Asia-Pacific Paliperidone Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Paliperidone Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Paliperidone Market Size by Type (2016-2027)
8.3 Asia-Pacific Paliperidone Market Size by Application
8.3.1 Asia-Pacific Paliperidone Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Paliperidone Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Paliperidone Market Size by Application (2016-2027)
8.4 Asia-Pacific Paliperidone Market Size by Region
8.4.1 Asia-Pacific Paliperidone Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Paliperidone Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Paliperidone Market Size (2016-2027)
9.2 Latin America Paliperidone Market Size by Type
9.2.1 Latin America Paliperidone Market Size by Type (2016-2021)
9.2.2 Latin America Paliperidone Market Size by Type (2022-2027)
9.2.3 Latin America Paliperidone Market Size by Type (2016-2027)
9.3 Latin America Paliperidone Market Size by Application
9.3.1 Latin America Paliperidone Market Size by Application (2016-2021)
9.3.2 Latin America Paliperidone Market Size by Application (2022-2027)
9.3.3 Latin America Paliperidone Market Size by Application (2016-2027)
9.4 Latin America Paliperidone Market Size by Country
9.4.1 Latin America Paliperidone Market Size by Country (2016-2021)
9.4.2 Latin America Paliperidone Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Paliperidone Market Size (2016-2027)
10.2 Middle East & Africa Paliperidone Market Size by Type
10.2.1 Middle East & Africa Paliperidone Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Paliperidone Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Paliperidone Market Size by Type (2016-2027)
10.3 Middle East & Africa Paliperidone Market Size by Application
10.3.1 Middle East & Africa Paliperidone Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Paliperidone Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Paliperidone Market Size by Application (2016-2027)
10.4 Middle East & Africa Paliperidone Market Size by Country
10.4.1 Middle East & Africa Paliperidone Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Paliperidone Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Janssen Pharmaceutica
11.1.1 Janssen Pharmaceutica Company Details
11.1.2 Janssen Pharmaceutica Business Overview
11.1.3 Janssen Pharmaceutica Paliperidone Introduction
11.1.4 Janssen Pharmaceutica Revenue in Paliperidone Business (2016-2021)
11.1.5 Janssen Pharmaceutica Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Paliperidone Introduction
11.2.4 Mylan Revenue in Paliperidone Business (2016-2021)
11.2.5 Mylan Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Paliperidone Introduction
11.3.4 Teva Revenue in Paliperidone Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Paliperidone Introduction
11.4.4 Sun Pharmaceutical Revenue in Paliperidone Business (2016-2021)
11.4.5 Sun Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Paliperidone Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 1.5 mg Tablet
Table 3. Key Players of 3 mg Tablet
Table 4. Key Players of 6 mg Tablet
Table 5. Key Players of 9 mg Tablet
Table 6. Global Paliperidone Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Paliperidone Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Paliperidone Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Paliperidone Market Share by Regions (2016-2021)
Table 10. Global Paliperidone Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Paliperidone Market Share by Regions (2022-2027)
Table 12. Paliperidone Market Trends
Table 13. Paliperidone Market Drivers
Table 14. Paliperidone Market Challenges
Table 15. Paliperidone Market Restraints
Table 16. Global Paliperidone Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Paliperidone Market Share by Players (2016-2021)
Table 18. Global Top Paliperidone Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paliperidone as of 2020)
Table 19. Ranking of Global Top Paliperidone Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Paliperidone Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Paliperidone Product Solution and Service
Table 23. Date of Enter into Paliperidone Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Paliperidone Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Paliperidone Revenue Market Share by Type (2016-2021)
Table 27. Global Paliperidone Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Paliperidone Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Paliperidone Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Paliperidone Revenue Market Share by Application (2016-2021)
Table 31. Global Paliperidone Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Paliperidone Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Paliperidone Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Paliperidone Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Paliperidone Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Paliperidone Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Paliperidone Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Paliperidone Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Paliperidone Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Paliperidone Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Paliperidone Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Paliperidone Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Paliperidone Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Paliperidone Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Paliperidone Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Paliperidone Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Paliperidone Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Paliperidone Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Paliperidone Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Paliperidone Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Paliperidone Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Paliperidone Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Paliperidone Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Paliperidone Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Paliperidone Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Paliperidone Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Paliperidone Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Paliperidone Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Paliperidone Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Paliperidone Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Paliperidone Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Paliperidone Market Size by Country (2022-2027) & (US$ Million)
Table 63. Janssen Pharmaceutica Company Details
Table 64. Janssen Pharmaceutica Business Overview
Table 65. Janssen Pharmaceutica Paliperidone Product
Table 66. Janssen Pharmaceutica Revenue in Paliperidone Business (2016-2021) & (US$ Million)
Table 67. Janssen Pharmaceutica Recent Development
Table 68. Mylan Company Details
Table 69. Mylan Business Overview
Table 70. Mylan Paliperidone Product
Table 71. Mylan Revenue in Paliperidone Business (2016-2021) & (US$ Million)
Table 72. Mylan Recent Development
Table 73. Teva Company Details
Table 74. Teva Business Overview
Table 75. Teva Paliperidone Product
Table 76. Teva Revenue in Paliperidone Business (2016-2021) & (US$ Million)
Table 77. Teva Recent Development
Table 78. Sun Pharmaceutical Company Details
Table 79. Sun Pharmaceutical Business Overview
Table 80. Sun Pharmaceutical Paliperidone Product
Table 81. Sun Pharmaceutical Revenue in Paliperidone Business (2016-2021) & (US$ Million)
Table 82. Sun Pharmaceutical Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paliperidone Market Share by Type: 2020 VS 2027
Figure 2. 1.5 mg Tablet Features
Figure 3. 3 mg Tablet Features
Figure 4. 6 mg Tablet Features
Figure 5. 9 mg Tablet Features
Figure 6. Global Paliperidone Market Share by Application: 2020 VS 2027
Figure 7. Adults Case Studies
Figure 8. Adolescents Case Studies
Figure 9. Paliperidone Report Years Considered
Figure 10. Global Paliperidone Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Paliperidone Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Paliperidone Market Share by Regions: 2020 VS 2027
Figure 13. Global Paliperidone Market Share by Regions (2022-2027)
Figure 14. Global Paliperidone Market Share by Players in 2020
Figure 15. Global Top Paliperidone Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paliperidone as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Paliperidone Revenue in 2020
Figure 17. Global Paliperidone Revenue Market Share by Type (2016-2021)
Figure 18. Global Paliperidone Revenue Market Share by Type (2022-2027)
Figure 19. North America Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Paliperidone Market Share by Type (2016-2027)
Figure 21. North America Paliperidone Market Share by Application (2016-2027)
Figure 22. North America Paliperidone Market Share by Country (2016-2027)
Figure 23. United States Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Paliperidone Market Share by Type (2016-2027)
Figure 27. Europe Paliperidone Market Share by Application (2016-2027)
Figure 28. Europe Paliperidone Market Share by Country (2016-2027)
Figure 29. Germany Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Paliperidone Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Paliperidone Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Paliperidone Market Share by Region (2016-2027)
Figure 39. China Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Paliperidone Market Share by Type (2016-2027)
Figure 47. Latin America Paliperidone Market Share by Application (2016-2027)
Figure 48. Latin America Paliperidone Market Share by Country (2016-2027)
Figure 49. Mexico Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Paliperidone Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Paliperidone Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Paliperidone Market Share by Country (2016-2027)
Figure 55. Turkey Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Paliperidone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Janssen Pharmaceutica Revenue Growth Rate in Paliperidone Business (2016-2021)
Figure 59. Mylan Revenue Growth Rate in Paliperidone Business (2016-2021)
Figure 60. Teva Revenue Growth Rate in Paliperidone Business (2016-2021)
Figure 61. Sun Pharmaceutical Revenue Growth Rate in Paliperidone Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[パリペリドンの世界市場規模・現状・予測2021年-2027年] (Global Paliperidone Market Size, Status and Forecast 2021-2027 / QY21JNE3928)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆